Neuropsychological Functioning in Children With Attention-Deficit/Hyperactivity Disorder.

Phase 4 Completed 40 enrolled Eli Lilly and Company

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the change in neuropsychological status from baseline to 6 months post-initiation of atomoxetine treatment in children ages 6 to 10.5 diagnosed with ADHD.

Timeline

Start: 2005-09
Primary completion: —
Completion: 2006-06

Publications

Dickson RA, Maki E, Gibbins C, Gutkin SW, Turgay A, Weiss MD. Time courses of improvement and symptom remission in children treated with atomoxetine for attention-deficit/hyperactivity disorder: analysis of Canadian open-label studies. Child Adolesc Psychiatry Ment Health. 2011 May 11;5:14. doi: 10.1186/1753-2000-5-14.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Atomoxetine	Other / unclassified	—	—

Neuropsychological Functioning in Children With Attention-Deficit/Hyperactivity Disorder.

Summary

Timeline

Publications

Drugs

Indications